Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Immune Ageing and the Gap Between Markers and Function: Study Summary

Previous related pageVitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence ReviewNext related pageVitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence Review
Study at a glance

What question did the studies ask?

Does vitamin D change immune ageing or persistent inflammation in older adults, and do those changes improve immune function? Studies measured cells, skin responses, vaccine antibodies and blood markers. Some experiments used cultured cells.

What did they find?

Selected cell-ageing markers decreased, and a local skin response improved. Other trials did not establish better measured immune function or vaccine responses. A VITAL analysis found a reduction in one inflammation marker at two years, but not four years. Several other markers did not improve.

What does this mean?

A laboratory change does not establish that the immune system becomes younger. A study needs to show that the change leads to meaningful improvement in function.

What are the limits?

Several studies were small or short. One clinical cohort appeared in two papers and is not two independent confirmations. Different populations and measurements limit comparison. These findings do not establish immune rejuvenation or an anti-ageing treatment.

Read the full article below ↓

Studies do not establish that taking extra vitamin D makes an older person’s immune system younger. Some studies found changes in selected cell measurements or a local skin response. Other trials did not find better immune function or a consistent reduction in inflammation. A laboratory change and a health benefit are different outcomes. Read the detailed review, Vitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence Review.

What was studied?

Researchers studied older adults with different health and vitamin D backgrounds. They measured immune-cell types, cell-ageing markers, responses to vaccination and inflammatory proteins in blood. Some experiments used cultured cells rather than people. These differences matter when applying a result to the people described in Vitamin D in Older Adults.

What changed?

An uncontrolled study followed 18 older adults during vitamin D replacement. The overall skin response to an antigen improved, but participants differed. An antigen is a substance recognised by the immune system. Without a randomised comparison group, the study could not establish that vitamin D caused the improvement. It did not prove protection from shingles or improvement throughout the body.

A related laboratory paper tested calcitriol, the active vitamin D hormone, in tissue cells. It found changes in selected inflammatory signals. Its human analysis reused the same 18 people, so it was not a second independent clinical confirmation.

A trial in 88 older adults found changes in some cell-ageing measurements under different vitamin D regimens, with or without N-acetylcysteine, a separate supplement. It did not demonstrate corresponding benefits in several blood inflammation markers or clinical immune protection. Its published correction must also be applied: a dose label was 5,000 international units, not 50,000 international units. These were research regimens, not personal instructions.

What did not show a clear benefit?

A small 12-week trial raised vitamin D concentrations without demonstrating better measured immune function. A separate influenza-vaccine trial in 38 older adults with low vitamin D did not establish an overall antibody benefit. The broader recall question is introduced in Vitamin D and Immune Memory. Recall means the response to something the immune system has encountered before.

In a one-year trial in older adults, most inflammatory markers did not clearly improve. A VITAL analysis found a reduction in one inflammation marker at two years, but not at four years. Several other markers did not improve. The study did not show that the temporary change caused better protection against infection.

Why are these distinctions important?

Immune ageing is not one blood test. A different mixture of cells does not automatically mean better or worse protection. In one small observational study, higher vitamin D was associated with fewer naïve T cells, which have not yet acquired antigen experience, and more effector T cells, which carry out immune responses. This could not show that vitamin D caused ageing or improved immunity.

Persistent inflammation, discussed in Vitamin D and Chronic Inflammation, is related to immune ageing. But lowering one marker does not establish that the immune system works better. Studies need to demonstrate that connection. The evidence includes useful biological clues and important findings that did not show a benefit; it does not establish immune rejuvenation or a general anti-ageing benefit from supplementation.

Sources

Related reading

Original sources

Source

Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing

Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.

Publication details

Sayegh et al. (2024). Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Aging Cell. 23(4):e14093. DOI: 10.1111/acel.14093.

Read more →
Source

Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial

Published in Frontiers in Immunology. 16:1570441. DOI: 10.3389/fimmu (2025).

Publication details

Rastgoo et al. (2025). Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Frontiers in Immunology. 16:1570441. DOI: 10.3389/fimmu.2025.1570441.

Read more →
Source

Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial

Published in Frontiers in Immunology. 16:1627178. Correction. DOI: 10.3389/fimmu (2025).

Publication details

Rastgoo et al. (2025). Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Frontiers in Immunology. 16:1627178. Correction. DOI: 10.3389/fimmu.2025.1627178.

Read more →
Source

Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial

This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.

Publication details

Gonçalves-Mendes et al. (2019). Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Frontiers in Immunology. 10:65. DOI: 10.3389/fimmu.2019.00065.

Read more →
Source

Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial

Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.

Publication details

Dong et al. (2022). Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Nutrients. 14(24):5307. DOI: 10.3390/nu14245307.

Read more →